Clinical trials have suggested that different types of the KD significantly improve the quality of life and daily function and eased AD-related cognitive impairment, especially in individuals without the epsilon 4 allele of the apolipoprotein E gene (APOE ɛ4). Here, APOE is linked to Cognitive impairment.